Cost-Effectiveness Analysis of Conbercept Versus Ranibizumab For The Treatment of Age-Related Macular Degeneration In China
Abstract
Authors
M Zhao W Feng L Zhang X Ke W Zhang J Xuan
M Zhao W Feng L Zhang X Ke W Zhang J Xuan
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now